Navigation Links
NeurogesX Reports First Quarter 2011 Results
Date:4/29/2011

e Act. Examples of such statements include but are not limited to: statements regarding expectations regarding the submission of the supplemental new drug application for label expansion of Qutenza, expectations regarding the Company's Phase 2 clinical trial of NGX-1998 and expected operating expenses, including moderated expense growth, for 2011.  Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to: difficulties or delays in the commercialization of Qutenza, including with respect to the successful marketing or manufacture and supply of Qutenza; physician or patient reluctance to use Qutenza, despite efforts and strategies to commercialize Qutenza; difficulties or delays in the further development of Qutenza for additional indications, including difficulties or delays in the submission of the sNDA for Qutenza; and difficulties or delays in the clinical development of NGX-1998.  For further information regarding these and other risks related to NeurogesX' business, investors should consult NeurogesX' filings with the Securities and Exchange Commission. NEUROGESX, INC.Condensed Consolidated Statements of Operations(in thousands, except share and per share information)Three Months EndedMarch 31,20112010 Net product revenue

$
575$
8212; Collaboration revenue

2,5951,786Total revenue

3,1701,786Operating expenses:Cost of goods sold

108—Research and development

3,9572,123Selling, general and administrative

10,2828,806Total operating expenses

14,34710,929Loss from operations

(11,177)(9,143)Interest income

278Interest expense

(2,200)(4)Other income (expense), net

(13)(24)Net loss

$
(13,363)$
(9,163)Basic and diluted net loss per share$
(0.75)$
(0.52)Shares used to compute basic and diluted net loss per share

17,870,34717,726,1
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. NeurogesX Receives Notice of Allowance for Patent Covering NGX-1998 Capsaicin Topical Liquid
2. NeurogesX Reports Fourth Quarter and Year-End 2010 Results
3. NeurogesX to Provide Qutenza® Launch Update
4. NeurogesX to Present at Two February Investor Conferences
5. NeurogesX Receives Qutenza®-Specific J-Code From Centers for Medicare and Medicaid Services (CMS)
6. NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation
7. NeurogesX to Hold Conference Call to Discuss Third Quarter 2010 Results
8. NeurogesX to Present at Oppenheimer & Co Healthcare Conference
9. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
10. NeurogesX Appoints Seasoned Sales and Marketing Executive as New Board Director
11. NeurogesX Receives FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 /CNW/ - Covalon Technologies ... medical technologies company, today announced the issuance of an ... of the Company and an aggregate of 120,500 stock ... stock options will vest over three years and will ... an exercise price of $1.40 per stock option. ...
(Date:3/27/2015)... 2015 /PRNewswire/ - Medicure Inc. (the "Company") (TSXV:MPH, OTCQB:MCUJF) ... the grant of an aggregate of 236,070 options to ... of the Company pursuant to the Company,s Stock Option ... on the tenth anniversary of the date of grant, ... of the date of grant and 50,000 are set ...
(Date:3/27/2015)... Ga. , March 27, 2015  Holographic Optical ... in the field of holographic medical imaging, is entering ... its Kickstarter campaign. Launching on April 20 th , ... and Voxbox Pro. The 8-inch and 22-inch displays will ... home for the first time. In addition to the ...
Breaking Medicine Technology:Covalon Announces Issuance of Stock Options 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3
... the progression of heart failure in asymptomatic and mildly ... Boston Scientific Corporation (NYSE: BSX ) ... today announced that the landmark MADIT-CRT trial has met ... cardiac resynchronization therapy defibrillators (CRT-Ds) to be associated with ...
... Secrets of a Childhood Cancer-- , , PHILADELPHIA, June ... Philadelphia advance the search for genetic events that result in ... , Originating in the peripheral nervous system, neuroblastoma is the ... percent of all childhood cancer deaths. , , "Only ...
Cached Medicine Technology:MADIT-CRT Trial Meets Primary Endpoint 2MADIT-CRT Trial Meets Primary Endpoint 3MADIT-CRT Trial Meets Primary Endpoint 4Gene Findings Unlocking Reasons for Neuroblastoma Risk 2Gene Findings Unlocking Reasons for Neuroblastoma Risk 3Gene Findings Unlocking Reasons for Neuroblastoma Risk 4
(Date:3/27/2015)... 27, 2015 Healthpointe is proud to ... M.D., is now treating knee and hip joint disorders ... , Long Beach, and La Mirada. Dr. Stanley Katz ... and hip joint disorders as well as chronic conditions ... in returning his patients back to their normal lives. ...
(Date:3/27/2015)... While deep learning was the topic of ... (GTC) , the CEO of one start-up spoke passionately about ... lifespan well beyond the generally-agreed ceiling of 120 years. , ... one of 12 companies recognized as the hottest GPU-powered startups ... GTC Emerging Companies Summit have business models focused ...
(Date:3/27/2015)... On March 19, 2015, at ... Lions wide receiver Herman Moore, hosted “Fighting Addiction ... substance abuse, treatment options and the recent changes ... pastors, ministers and bishops from local churches as ... , “Our ‘Fighting Addiction Together’ luncheon was informative ...
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 GenSight, ... it has appointed Sean Fitzgerald, a former technology and ... Operating Officer and Interim Chief Financial Officer. , Mr ... education technology innovator, EverFi, backed by Amazon founder and ... founder Evan Williams. Prior to EverFi, he was a ...
(Date:3/27/2015)... When struck with the aftermath of a trucking ... begin. The latest eBook released by Dax Jones ... victims a clear and concise process for obtaining the ... injury claim is seen through to successful completion. , ... should be taken immediately following the trucking incident. From ...
Breaking Medicine News(10 mins):Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 2Health News:Fellowship-Trained and Board-Certified Orthopedic Surgeon is Now Treating Knee and Hip Joint Disorders in Anaheim, California 3Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 2Health News:InSilico Medicine, Inc. Stands Out from High Tech Startups at 2015 GPU Conference 3Health News:LiveToBeSober.org Hosts Conference on Substance Abuse Treatment and Recovery at Ford Field 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Dax Jones Updated eBook on Trucking Accidents Offers Helpful Information to Crash Victims 2
... , MURRIETA, Calif., Sept. 16 Forterus ... drug and alcohol rehabilitation and a variety of other behavioral healthcare ... has updated its web sites at www.forterushealthcare.com ... , , "It is very important that visitors ...
... ... of scientifically targeted nutritional stacks developed by Max Muscle Sport Nutrition available online at ... Anaheim, CA ... of all time, Max Muscle Sports Nutrition athlete and UFC 106 heavyweight title contender Shane ...
... ... summarized within Smart But Feeling Dumb, Dr. Levinson,s groundbreaking research effort has demonstrated ... ADD, Dyspraxia, Anxiety, Phobias, Panic, etc.) all result from a signal scrambling dysfunction ... - 85% of treated patients respond favorably to inner-ear-enhancing medications and nutrients. ...
... Sept. 15 The following was released today by True Torah Jews: ... are concerned about the ongoing accusations of an Israeli hospital, Hadassah, against ... at 50 W. 58th St. this Wednesday, September 16 at 3:30 PM. ... half years of age, was hospitalized at Hadassah on and off for ...
... ... stockholders, agree on ten crucial issues at the center of the health care debate, according ... ... Two groups that drive the American economy, small business owners and stockholders, agree on ten ...
... NEW YORK, Sept. 15 The phrase "High Five" has a ... also about the importance of losing weight. , , ... http://inr.mediaseed.tv/oneClip_C/?feed=aHmxldfx7n1A1TL9XeQmBSEb7YP2NUTr , , Registered journalists can ... use at http://www.mediaseed.tv . , , ...
Cached Medicine News:Health News:Forterus Inc. Launches Updated, Improved Web Site 2Health News:UFC Title Fight Has Stacked Advantage 2Health News:UFC Title Fight Has Stacked Advantage 3Health News:UFC Title Fight Has Stacked Advantage 4Health News:Back to School - Dramatic Medical Help and Hope for the Learning Disabled 2Health News:Back to School - Dramatic Medical Help and Hope for the Learning Disabled 3Health News:American Jews to Protest Against Hadassah Hospital 2Health News:Small Business Owners and Stockholders Agree on Ten Crucial Health Care Reform Issues, According to New Zogby/O'Leary Poll 2Health News:Small Business Owners and Stockholders Agree on Ten Crucial Health Care Reform Issues, According to New Zogby/O'Leary Poll 3Health News:Small Business Owners and Stockholders Agree on Ten Crucial Health Care Reform Issues, According to New Zogby/O'Leary Poll 4
One inch disposable patch electrode uses a specially formulated adhesive solid gel. Reusable lead wire with snap connector provides economic benefits. Ideal for sleep studies where leg movement or EK...
... Made with elastic fabric, these head cap ... need to begin testing. Each Electro-Cap System ... the International 10-20 System. When you place ... are using with your head cap system ...
... When testing takes you into the OR, ER, ... protection of Cadwells new shielded electrodes. Keeping noise ... and paired disc electrode has a special shielded ... the damaging effects of 60-cycle interference. That means ...
... 3 (Binocular Indirect Ophthalmo-Microscope) incorporates the principle of ... a view of up to 130 degrees of ... the eye may be rotated freely so that ... Even surgery through small pupils is possible. ...
Medicine Products: